Literature DB >> 32820887

Polyamidoamine Dendrimer Grafted with an Acid-Responsive Charge-Reversal Layer for Improved Gene Delivery.

Juan Wang1,2, Remy C Cooper3, Hu Yang2,4,5.   

Abstract

We report on a heterogeneous dendrimer (G3-acetal-NH2) derivative possessing an acid-responsive charge-reversal layer. The synthesis of G3-acetal-NH2 starts with a polyamidoamine (PAMAM) dendrimer G3 core and follows the aza-Michael addition with N-(2-(1-(allyloxy)ethoxy)ethyl)acrylamide synthesized by us and the thiol-ene click chemistry with cysteamine hydrochloride in sequence. In a weakly acidic environment, the surface of this newly formed dendrimer can turn from amine-terminated to hydroxyl-terminated due to the cleavage of the acetal groups. This charge conversion from 34.3 ± 2.7 to 18.0 ± 0.3 mV in 24 h at pH 5.3 enables its capacity as a gene delivery vehicle. G3-acetal-NH2 with a positively charged surface can condense pMAX GFP plasmid at similar weight ratios as native G4-NH2 (above 2:1), allowing for its protected uptake into cells and endosomal escape. Meanwhile, in the endosome, the drop in vesicle pH cleaves the acetal bond, releasing the genetic payload and limiting its recondensation by the reduction in the dendrimer surface charge. When the vector/plasmid weight ratio was 2:1, G3-acetal-NH2 improved transfection of pMAX GFP plasmid by 5-fold over native G4-NH2 in NIH3T3 cells in terms of GFP protein expression. Taken together, we show that this surface charge conversion performance makes the synthesized heterogeneous dendrimer an improved vehicle for gene transfection.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32820887      PMCID: PMC7583228          DOI: 10.1021/acs.biomac.0c00580

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  25 in total

1.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

2.  PEGylated polyamidoamine dendrimers with bis-aryl hydrazone linkages for enhanced gene delivery.

Authors:  Quan Yuan; W Andrew Yeudall; Hu Yang
Journal:  Biomacromolecules       Date:  2010-08-09       Impact factor: 6.988

Review 3.  Gene therapy clinical trials worldwide to 2017: An update.

Authors:  Samantha L Ginn; Anais K Amaya; Ian E Alexander; Michael Edelstein; Mohammad R Abedi
Journal:  J Gene Med       Date:  2018-04-19       Impact factor: 4.565

4.  Ultrasensitive pH Triggered Charge/Size Dual-Rebound Gene Delivery System.

Authors:  Xiuwen Guan; Zhaopei Guo; Lin Lin; Jie Chen; Huayu Tian; Xuesi Chen
Journal:  Nano Lett       Date:  2016-10-24       Impact factor: 11.189

5.  Hydrophobic modification of low molecular weight polyethylenimine for improved gene transfection.

Authors:  Pei Yun Teo; Chuan Yang; James L Hedrick; Amanda C Engler; Daniel J Coady; Sadaf Ghaem-Maghami; Andrew J T George; Yi Yan Yang
Journal:  Biomaterials       Date:  2013-07-21       Impact factor: 12.479

6.  Esterase-Activated Charge-Reversal Polymer for Fibroblast-Exempt Cancer Gene Therapy.

Authors:  Nasha Qiu; Xiangrui Liu; Yin Zhong; Zhuxian Zhou; Ying Piao; Lei Miao; Qianzhi Zhang; Jianbin Tang; Leaf Huang; Youqing Shen
Journal:  Adv Mater       Date:  2016-10-27       Impact factor: 30.849

7.  Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

Authors:  Yuhua Wang; Hsing-Hao Su; Yang Yang; Yunxia Hu; Lu Zhang; Pilar Blancafort; Leaf Huang
Journal:  Mol Ther       Date:  2012-12-11       Impact factor: 11.454

8.  Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes.

Authors:  N D Sonawane; Francis C Szoka; A S Verkman
Journal:  J Biol Chem       Date:  2003-08-27       Impact factor: 5.157

9.  Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.

Authors:  Xin Liu; Jiajia Xiang; Dingcheng Zhu; Liming Jiang; Zhuxian Zhou; Jianbin Tang; Xiangrui Liu; Yongzhuo Huang; Youqing Shen
Journal:  Adv Mater       Date:  2015-12-14       Impact factor: 30.849

Review 10.  Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.

Authors:  Julien Baruteau; Simon N Waddington; Ian E Alexander; Paul Gissen
Journal:  J Inherit Metab Dis       Date:  2017-05-31       Impact factor: 4.982

View more
  2 in total

Review 1.  Charge reversal nano-systems for tumor therapy.

Authors:  Peng Zhang; Daoyuan Chen; Lin Li; Kaoxiang Sun
Journal:  J Nanobiotechnology       Date:  2022-01-10       Impact factor: 10.435

Review 2.  Dendrimer-based drug delivery systems: history, challenges, and latest developments.

Authors:  Juan Wang; Boxuan Li; Li Qiu; Xin Qiao; Hu Yang
Journal:  J Biol Eng       Date:  2022-07-25       Impact factor: 6.248

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.